Skip to main content

Table 1 Baseline Characteristics of the Subjects

From: Rivastigmine improves dual-task gait velocity in patients with Alzheimer’s disease

Age (mean, SD) 79.03 (6.89)
Sex (female; n, %) 13 (61.9%)
Mini-Mental State Examination (mean, SD) 19.62 (4.71)
Geriatric Depression Scale (mean, SD) 2.76 (1.09)
Functional Assessment Staging (mean, SD) 4.24 (0.83)
Alzheimer’s Disease Cooperative Study Activities of Daily Living (mean, SD) 63.14 (8.6)
Single-task gait trials velocity (m/min) stride length (cm) cadence (steps/min)
 Normal gait (mean, SD) 59.21 (12.21) 50.11 (7.52) 117.69 (12.26)
 Fast gait (mean, SD) 70.33 (16.06) 54.64 (8.58) 127.69 (13.37)
Dual-task gait trials
 Counting backward by 7 40.59 (13.59) 46 (9.29) 95.38 (23.88)
 Naming animals 37.06 (15.57) 46.25 (9.24) 80.46 (27.15)
  1. SD Standard deviation